The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Curcuminoids exert glucose‐lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double‐blind, placebo‐controlled trial
Abstract
Scope: We previously found that curcuminoids decreased blood glucose and improved insulin resistance by reducing serum free fatty acids (FFA s) and increasing fatty acid oxidation in skeletal muscle of diabetic rats. This study was to investigate whether curcuminoids have beneficial effects on type 2 diabetic patients, and its possible mechanisms. Methods and results: Overweight/obese type 2 diabetic patients (BMI ≥ 24.0; fasting blood glucose ≥ 7.0 mmol/L or postprandial blood glucose ≥11.1 mmol/L) were randomly assigned to curcuminoids (300 mg/day) or placebo for 3 months. Bodyweight, glycosylated hemoglobin A 1c (H b A1c,%), serum fasting glucose, FFA s, lipids, and lipoprotein lipase (LPL) were determined. A total of 100 patients (curcuminoids, n = 50; placebo, n = 50) completed the trial. Curcuminoids supplementation significantly decreased fasting blood glucose (p < 0.01), H b A1c (p = 0.031), and insulin resistance index (HOMA‐IR) (p < 0.01) in type 2 diabetic patients. Curcuminoids also led to a significant decrease in serum total FFA s (p < 0.01), triglycerides (P = 0.018), an increase in LPL activity (p < 0.01). Conclusion: These findings suggest a glucose‐lowering effect of curcuminoids in type 2 diabetes, which is partially due to decrease in serum FFAs, which may result from promoting fatty acid oxidation and utilization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wild, S., Roglic, G., Green, A., Sicree, R., & King, H. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1047 · Cited by 15,297
Dose translation from animal to human studies revisited.
Reagan‐Shaw, S., Nihal, M., & Ahmad, N. (2008) · The FASEB Journal · doi:10.1096/fj.07-9574lsf · Cited by 6,524
Trumbo, P., Schlicker, S., Yates, A. A., & Poos, M. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90346-9 · Cited by 5,993
IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030
Whiting, D. R., Guariguata, L., Weil, C., & Shaw, J. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.10.029 · Cited by 3,994
Lipoprotein lipase: structure, function, regulation, and role in disease
Mead, J., Irvine, S., & Ramji, D. (2002) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0384-9 · Cited by 927
Sandur, S. K., Pandey, M. K., Sung, B., Ahn, K. S., Murakami, A., Sethi, G., Limtrakul, P., Badmaev, V., & Aggarwal, B. B. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm123 · Cited by 687
Cameron, A. J., Zimmet, P. Z., Dunstan, D. W., Dalton, M., Shaw, J. E., Welborn, T. A., Owen, N., Salmon, J., & Jolley, D. (2003) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2003.tb05283.x · Cited by 596
Curcumin Inhibits Adipogenesis in 3T3-L1 Adipocytes and Angiogenesis and Obesity in C57/BL Mice
Ejaz, A., Wu, D., Kwan, P., & Meydani, M. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.100966 · Cited by 585
Cameron, A. J., Zimmet, P. Z., Dunstan, D. W., Dalton, M., Shaw, J. E., Welborn, T. A., Owen, N., Salmon, J., & Jolley, D. (2004) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2004.tb05998.x · Cited by 534
Weisberg, S. P., Leibel, R., & Tortoriello, D. V. (2008) · Endocrinology · doi:10.1210/en.2008-0262 · Cited by 480
Cited by
Curcumin: A Review of Its Effects on Human Health
Hewlings, S., & Kalman, D. (2017) · Foods · doi:10.3390/foods6100092 · Cited by 2,720
“Curcumin has been shown to attenuate several aspects of MetS by improving insulin sensitivity [43,44], suppressing adipogenesis [45], and reducing elevated blood pressure [46], inflammation [47], and oxidative stress [48,49].”
BackgroundTranscription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Cuadrado, A., Manda, G., Hassan, A., Alcaraz, M. J., Barbas, C., Daiber, A., Ghezzi, P., León, R., López, M. G., Oliva, B., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014753 · Cited by 632
“In T2DM patients, curcumin decreases the levels of fasting blood glucose, glycated hemoglobin, serum free fatty acids, triglycerides, and uric acid, and increases the levels of lipoprotein lipase (Na et al., 2013; Chuengsamarn et al., 2014).”
BackgroundSoleimani, V., Sahebkar, A., & Hosseinzadeh, H. (2018) · Phytotherapy Research · doi:10.1002/ptr.6054 · Cited by 579
The therapeutic potential of curcumin: A review of clinical trials
Salehi, B., Stojanović-Radić, Z., Matejić, J., Sharifi-Rad, M., Anil Kumar, N. V., Martins, N., & Sharifi-Rad, J. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.12.016 · Cited by 495
Ghosh, S., Banerjee, S., & Sil, P. C. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.05.022 · Cited by 491
Activators and inhibitors of NRF2: a review of their potential for clinical development
Robledinos-Antón, N., Fernández-Ginés, R., Manda, G., & Cuadrado, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/9372182 · Cited by 413
Panahi, Y., Hosseini, M. S., Khalili, N., Naimi, E., Majeed, M., & Sahebkar, A. (2015) · Clinical Nutrition · doi:10.1016/j.clnu.2014.12.019 · Cited by 406
Curcumin and Type 2 Diabetes Mellitus: Prevention and Treatment
Pivari, F., Mingione, A., Brasacchio, C., & Soldati, L. (2019) · Nutrients · doi:10.3390/nu11081837 · Cited by 375
Tsuda, T. (2018) · Food & Function · doi:10.1039/c7fo01242j · Cited by 367
Curcuminoid Treatment for Knee Osteoarthritis: A Randomized Double‐Blind Placebo‐Controlled Trial
Panahi, Y., Rahimnia, A., Sharafi, M., Alishiri, G., Saburi, A., & Sahebkar, A. (2014) · Phytotherapy Research · doi:10.1002/ptr.5174 · Cited by 310
Panahi, Y., Kianpour, P., Mohtashami, R., Jafari, R., Simental-Mendía, L., & Sahebkar, A. (2017) · Drug Research · doi:10.1055/s-0043-100019 · Cited by 286
Curcuminoids for the management of hypertriglyceridaemia
Sahebkar, A. (2014) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.140-c1 · Cited by 172
Thota, R. N., Acharya, S. H., & Garg, M. L. (2019) · Lipids in Health and Disease · doi:10.1186/s12944-019-0967-x · Cited by 127
Caloric Restriction Mimetics in Nutrition and Clinical Trials
Hofer, S. J., Davinelli, S., Bergmann, M., Scapagnini, G., & Madeo, F. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.717343 · Cited by 109
Sohaei, S., Amani, R., Tarrahi, M. J., & Ghasemi-Tehrani, H. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102201 · Cited by 100
Das, D., Shruthi, N. R., Banerjee, A., Jothimani, G., Duttaroy, A. K., & Pathak, S. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1221438 · Cited by 90
“Obesity, IR, and inflammatory processes are all reduced in those with MetS (244).”
BackgroundAltobelli, E., Angeletti, P. M., Marziliano, C., Mastrodomenico, M., Giuliani, A. R., & Petrocelli, R. (2021) · Nutrients · doi:10.3390/nu13020404 · Cited by 67
Metadata
- Authors
- Na, L., Li, Y., Pan, H., Zhou, X., Sun, D., Meng, M., Li, X., & Sun, C.
- Venue
- Molecular Nutrition & Food Research
- Publisher
- Wiley
- Published
- 2012-08-29
- Volume
- 57
- Issue
- 9
- Pages
- 1569-1577
- ISSN
- 1613-4125 (ISSN-L)
- 1613-4133
- OpenAlex
- W2171735019
- Cited by
- 269
- References
- 41
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.